Omega-3 deficiency symptoms

Short answer

According to the NIH, essential fatty acid (omega-3 or omega-6) deficiency can cause rough, scaly skin and dermatitis; according to the NIH, classic deficiency is almost never seen in healthy people in the US, and clinical findings have mostly been described in patients receiving parenteral nutrition that contains no fatty acids. For DHA or EPA there is no known cutoff at which visual, neural or immune functions are impaired; therefore there is no verified criterion linking a particular complaint to omega-3 deficiency. Low intake and deficiency are also not the same thing. ^[1]

Does omega-3 deficiency really exist?

Yes, but the defined clinical picture is narrow and does not correspond to the broad symptom lists circulating online under the name “omega-3 deficiency.” The NIH reports that deficiency of essential fatty acids (omega-3 or omega-6) can cause rough, scaly skin and dermatitis, and that in omega-3 deficiency plasma and tissue DHA levels fall; on the other hand, there is no known DHA or EPA threshold at which functional outcomes such as visual or neural function or immune response are impaired. ^[1]

The NIH states that classic deficiency is almost never seen in healthy people in the US: when there is an energy deficit together with fat restriction or malabsorption, the body releases essential fatty acids from its stores in adipose tissue. According to the NIH, clinical findings of deficiency have therefore generally been seen in patients receiving parenteral nutrition without PUFAs; the cases were reported in the 1970s and 1980s, and current enteral and parenteral nutrition solutions contain sufficient PUFAs. ^[1]

A 2025 narrative review likewise says that essential fatty acid deficiency can arise under conditions of inadequate fat intake, malabsorption, malnutrition and altered fat metabolism. Patients dependent on parenteral nutrition need to receive adequate essential fatty acids through lipid emulsions; the review also notes that relying on the Holman index (triene:tetraene ratio) alone can lead to misdiagnosis. ^[2] This deficiency concerns linoleic acid (omega-6) and alpha-linolenic acid (ALA, omega-3); EPA and DHA are a separate matter.

Does low omega-3 intake mean deficiency?

No. They are two separate concepts. EFSA bases its adequate intake (AI) value of 250 mg/day for EPA+DHA on an assessment of cardiovascular health; an AI was set because an average requirement could not be derived. ^[4] The US National Academy of Medicine (IOM) values that the NIH relies on are also only for ALA, for ages 1 and over, and are AIs based on intakes observed in healthy populations; no separate recommendation is given for EPA or DHA. ^[1] Falling below a reference value does not mean that the person has impaired function. The Ministry of Health National Nutrition Council (UBK) report recommends 300 mg/day EPA+DHA; for ALA it states that 0.5–0.6% of energy prevents signs of deficiency. ^[5]

The NIH reports that dietary EPA and DHA intake in US adults is about 90 mg/day (NHANES 2011–2012); that is, intake below reference values is common in the US, but these population intake data are specific to the US. ^[1] For Türkiye, instead of direct EPA+DHA intake data there is an indirect indicator: a review reporting TÜİK (2016) data states that annual per-capita fish consumption fell from 8.0 kg in 2000 to 6.1 kg in 2015 and is far below the world average. ^[6] These data date from 2015.

Who may have low intake?

• People who do not eat fish and seafood. The main dietary source of EPA and DHA is fish. The Ministry of Health UBK report states that the diets of vegetarians, especially vegans, contain less omega-3 fatty acids than those of non-vegetarians, and that pesco-vegetarians who eat only fish differ. ^[5]
• People with fat malabsorption or severe malnutrition. Essential fatty acid deficiency has been described under these conditions. ^[2]
• People receiving parenteral nutrition without fat. Cases have historically been reported in these patients; current solutions contain sufficient PUFAs. ^[1]

Beyond these, there is no verified list that identifies who is “at risk”; how reference values differ in pregnancy and lactation is given in the main guide and on the foods page.

Detailed guideWhich foods contain omega-3? Serving table and fish of Türkiye→

Fatigue, dry eye, hair loss: are they signs of omega-3 deficiency?

There is no verified association. The NIH reports that there is no cutoff for DHA or EPA at which functional outcomes are impaired ^[1] and concludes that no consistent association has been found between omega-3 and dry eye. ^[1] Therefore the inference “I am tired, so I must have omega-3 deficiency” cannot be made; these complaints can have many other causes. In supplement trials, no benefit has been shown in areas such as dry eye, ADHD and cognitive function; details are on the benefits page.

Detailed guideOmega-3 benefits: which claims are supported?→

Rough, scaly skin and dermatitis, on the other hand, are the defined findings of essential fatty acid deficiency; however, this finding alone does not prove omega-3 deficiency, and skin symptoms can have other causes. When there is an underlying condition such as fat malabsorption, severe malnutrition or parenteral nutrition, assessment is a matter for a physician.

What does the omega-3 index test say?

According to the NIH, most physicians do not measure omega-3 status; when measured, EPA and DHA in plasma or serum phospholipids are expressed as a percentage of total phospholipid fatty acids. Normal ranges have not been established; in US adults not taking omega-3 supplements, the mean serum or plasma phospholipid EPA+DHA is about 3–4%. Because plasma and serum values change markedly with the most recent meal, they do not reflect long-term intake. ^[1]

Erythrocyte membrane fatty acids, by contrast, reflect intake over roughly the previous 120 days. The omega-3 index proposed by Harris and von Schacky is the percentage of EPA+DHA in the erythrocyte membrane relative to total erythrocyte fatty acids, and can be used as a proxy for tissue EPA+DHA level. EPA and DHA make up about 3–5% of erythrocyte fatty acids in Western societies, where fish consumption is low; in Japan this level is about twice as high. ^[1]

Harris and von Schacky (2004) report that the omega-3 index is inversely associated with the risk of death from coronary heart disease, with an index of 8% and above associated with the highest cardioprotective association and 4% and below with the lowest protection. This is a proposal for a risk indicator and is based on observational data; the authors suggested that the index “may be a new risk factor.” ^[3] These are not diagnostic thresholds: the NIH reports that normal ranges have not been established; moreover, raising the index with supplements has not been shown in large randomized trials to improve cardiovascular outcomes in the general adult population (main guide).

Detailed guideWhat is omega-3? EPA, DHA, ALA, evidence and safety→

Can deficiency be corrected?

In clinical essential fatty acid deficiency (in situations such as parenteral nutrition), treatment is given with lipid emulsions containing essential fatty acids and under physician management. ^[2] In healthy people, the practical way to increase intake is to obtain EPA and DHA directly from food or supplements; conversion from ALA is limited. ^[1] Which fish contain how much and the types of supplements are on separate pages.

Detailed guideFish oil: forms, krill, algal oil and label reading→

This guide does not recommend personal doses; the decision on testing and supplements is made with a physician, taking the person’s conditions and medications into account.